EichorEICHOR
Location: Nijmegen Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Nijmegen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Radboudumc · Eli Lilly and Company · NCT07218380
Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NA · Canisius Wilhelmina Ziekenhuis · Amsterdam UMC, location VUmc · NCT05350722
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Canisius-Wilhelmina Ziekenhuis · Pfizer · NCT07028853
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodro
Phase 2 · Radboud University · Michael J. Fox Foundation for Parkinson's Research · NCT07265596
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Amalia Children's Hospital, Radboudumc · The Hospital for Sick Children · NCT06560606
Ten Year Follow-up in FSHD: the FOCUS 3 Study
Phase N/A · Radboudumc · Radboud University Medical Center · NCT06911190
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Radboud Universitair Medisch Centrum · Amgen · NCT07037433
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · Sint Maartenskliniek Nijmegen · Sint Maartenskliniek · NCT07160231
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · Radboudumc · Deciphera Pharmaceuticals, LLC · NCT05957367
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/Phase 2 · Radbout University Medical Centre · Vico Therapeutics B. V. · NCT05822908
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Radboudumc · Alimentiv Inc. · NCT07363044
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Radboud Umcn · Janssen Research & Development, LLC · NCT07499232
Use of Physiology to Evaluate Procedural Result After PCI CTO
NA · Radboud UMC · Isala · NCT04780971
An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreati
Phase N/A · RadboudUMC · Radboud University Medical Center · NCT05267379
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Radboudumc · Eli Lilly and Company · NCT06937086
Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
Phase N/A · Radboudumc · Haaglanden Medical Centre · NCT05851989
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
NA · Radboud UMC · Erasmus Medical Center · NCT06644716
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943
Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)
NA · Radboudumc · Radboud University Medical Center · NCT06209723
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Radboudumc Nijmegen · Daiichi Sankyo · NCT06330064
Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer
Phase 2 · RadboudUMC · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT03379909
Effectiveness of Focal Therapy in Men With Prostate Cancer
NA · Radboud University Medical Centre · Radboud University Medical Center · NCT06223295
Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Canisius Wilhelmina Hospital · Maastricht University Medical Center · NCT04486495
A Study With CIT-013 in RA Patients
Phase 2 · NL-03 · Citryll BV · NCT06567470
Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS
NA · Radboud UMC · Amsterdam UMC, location VUmc · NCT05900271
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06562192
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Radboudumc ( Site 1706) · Merck Sharp & Dohme LLC · NCT06623422
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Radboud Universitair Medisch Centrum · Takeda · NCT06963827
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Radboudumc · Daiichi Sankyo · NCT06731478
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · Radboud Univeristy Medical Centre · Leiden University Medical Center · NCT05393791
Look up another city
Look up another condition